NuCana PLC logo

NuCana PLC - ADR

NAS:NCNA (UK)   ADR
$ 3.81 -0.03 (-0.78%) 10:09 PM EST
At Loss
P/B:
0.43
Enterprise V:
$ -13.26M
Volume:
16.24K
Avg Vol (2M):
106.39K
Also Trade In:
Volume:
16.24K
At Loss
Avg Vol (2M):
106.39K

Business Description

NuCana PLC logo
NuCana PLC
NAICS : 325412 SIC : 2834
ISIN : US67022C1062

Share Class Description:

NCNA: ADR
Description
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 43.43
Equity-to-Asset 0.54
Debt-to-Equity 0.03
Debt-to-EBITDA -0.01
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 21.06
9-Day RSI 22.96
14-Day RSI 27.16
6-1 Month Momentum % -41.89
12-1 Month Momentum % -65.25

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.97
Quick Ratio 1.97
Cash Ratio 1.36

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.1
Shareholder Yield % -4.66
Name Current Vs Industry Vs History
ROE % -103.62
ROA % -66.22
ROIC % -458.12
ROC (Joel Greenblatt) % -4482.04
ROCE % -115.21

Financials (Next Earnings Date:2024-05-17 Est.)

NCNA's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NCNA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

NuCana PLC Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -16.477
Beta 2.1
Volatility % 35.12
14-Day RSI 27.16
14-Day ATR ($) 0.748824
20-Day SMA ($) 5.06575
12-1 Month Momentum % -65.25
52-Week Range ($) 3.4 - 23.75
Shares Outstanding (Mil) 2.11

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

NuCana PLC Filings

Filing Date Document Date Form
No Filing Data

NuCana PLC Stock Events

Financials Calendars
Event Date Price($)
No Event Data

NuCana PLC Frequently Asked Questions

What is NuCana PLC(NCNA)'s stock price today?
The current price of NCNA is $3.81. The 52 week high of NCNA is $23.75 and 52 week low is $3.40.
When is next earnings date of NuCana PLC(NCNA)?
The next earnings date of NuCana PLC(NCNA) is 2024-05-17 Est..
Does NuCana PLC(NCNA) pay dividends? If so, how much?
NuCana PLC(NCNA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1